Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kim Henriksen

Showing results (111-120 of 154) with videos related to

Pageof 16
Sort By:
Diabetologia|September 16, 2016
Serum endotrophin identifies optimal responders to PPARγ agonists in type 2 diabetesMorten A Karsdal, Kim Henriksen, Federica Genovese, et al.
Neurology. Genetics|November 2, 2020
Matrix metalloproteinase-degraded type I collagen is associated with <i>APOE/TOMM40</i> variants and preclinical dementiaMan-Hung Eric Tang, Joseph P M Blair, Cecilie Liv Bager, et al.
Molecular Therapy. Methods & Clinical Development|February 12, 2021
Gene therapy for infantile malignant osteopetrosis: review of pre-clinical research and proof-of-concept for phenotypic reversalIlana Moscatelli, Elena Almarza, Axel Schambach, et al.
Cartilage|June 13, 2015
Characterization of an Ex vivo Femoral Head Model Assessed by Markers of Bone and Cartilage TurnoverSuzi Hoegh Madsen, Anne Sofie Goettrup, Gedske Thomsen, et al.
Calcified Tissue International|August 20, 2016
Regulation and Function of Lentiviral Vector-Mediated TCIRG1 Expression in Osteoclasts from Patients with Infantile Malignant Osteopetrosis: Implications for Gene TherapyChristian Schneider Thudium, Ilana Moscatelli, Henrik Löfvall, et al.
American Journal of Physiology. Endocrinology and Metabolism|May 8, 2014
A novel oral dual amylin and calcitonin receptor agonist (KBP-042) exerts antiobesity and antidiabetic effects in ratsKim V Andreassen, Michael Feigh, Sara T Hjuler, et al.
Human Gene Therapy|July 21, 2017
Targeting NSG Mice Engrafting Cells with a Clinically Applicable Lentiviral Vector Corrects Osteoclasts in Infantile Malignant OsteopetrosisIlana Moscatelli, Henrik Löfvall, Christian Schneider Thudium, et al.
Medicine|September 8, 2016
Metabolic syndrome and subsequent risk of type 2 diabetes and cardiovascular disease in elderly women: Challenging the current definitionKatrine Dragsbæk, Jesper S Neergaard, Janne M Laursen, et al.
Journal of Translational Medicine|November 1, 2012
Future detection and monitoring of diabetes may entail analysis of both β-cell function and volume: how markers of β-cell loss may assistAnita V Neutzsky-Wulff, Kim V Andreassen, Sara T Hjuler, et al.
American Journal of Physiology. Endocrinology and Metabolism|October 4, 2023
Dual amylin and calcitonin receptor agonist treatment reduces biomarkers associated with kidney fibrosis in diabetic ratsSimone Anna Melander, Alexandra Louise Møller, Khaled Elhady Mohamed, et al.
Pageof 16

Showing results (111-120 of 154) with videos related to

Sort By:
Pageof 16
Diabetologia|September 16, 2016
Serum endotrophin identifies optimal responders to PPARγ agonists in type 2 diabetesMorten A Karsdal, Kim Henriksen, Federica Genovese, et al.
Neurology. Genetics|November 2, 2020
Matrix metalloproteinase-degraded type I collagen is associated with <i>APOE/TOMM40</i> variants and preclinical dementiaMan-Hung Eric Tang, Joseph P M Blair, Cecilie Liv Bager, et al.
Molecular Therapy. Methods & Clinical Development|February 12, 2021
Gene therapy for infantile malignant osteopetrosis: review of pre-clinical research and proof-of-concept for phenotypic reversalIlana Moscatelli, Elena Almarza, Axel Schambach, et al.
Cartilage|June 13, 2015
Characterization of an Ex vivo Femoral Head Model Assessed by Markers of Bone and Cartilage TurnoverSuzi Hoegh Madsen, Anne Sofie Goettrup, Gedske Thomsen, et al.
Calcified Tissue International|August 20, 2016
Regulation and Function of Lentiviral Vector-Mediated TCIRG1 Expression in Osteoclasts from Patients with Infantile Malignant Osteopetrosis: Implications for Gene TherapyChristian Schneider Thudium, Ilana Moscatelli, Henrik Löfvall, et al.
American Journal of Physiology. Endocrinology and Metabolism|May 8, 2014
A novel oral dual amylin and calcitonin receptor agonist (KBP-042) exerts antiobesity and antidiabetic effects in ratsKim V Andreassen, Michael Feigh, Sara T Hjuler, et al.
Human Gene Therapy|July 21, 2017
Targeting NSG Mice Engrafting Cells with a Clinically Applicable Lentiviral Vector Corrects Osteoclasts in Infantile Malignant OsteopetrosisIlana Moscatelli, Henrik Löfvall, Christian Schneider Thudium, et al.
Medicine|September 8, 2016
Metabolic syndrome and subsequent risk of type 2 diabetes and cardiovascular disease in elderly women: Challenging the current definitionKatrine Dragsbæk, Jesper S Neergaard, Janne M Laursen, et al.
Journal of Translational Medicine|November 1, 2012
Future detection and monitoring of diabetes may entail analysis of both β-cell function and volume: how markers of β-cell loss may assistAnita V Neutzsky-Wulff, Kim V Andreassen, Sara T Hjuler, et al.
American Journal of Physiology. Endocrinology and Metabolism|October 4, 2023
Dual amylin and calcitonin receptor agonist treatment reduces biomarkers associated with kidney fibrosis in diabetic ratsSimone Anna Melander, Alexandra Louise Møller, Khaled Elhady Mohamed, et al.
Pageof 16